BRIEF published on 08/12/2026 at 15:35, 30 days 7 hours ago Vanguard Discloses Stake in Tate & Lyle Plc Form 8.3 Disclosure Takeover Code Vanguard Tate & Lyle
BRIEF published on 08/12/2026 at 15:34, 30 days 7 hours ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Takeover Code Vanguard Group Spire Healthcare Stockholding
PRESS RELEASE published on 08/12/2026 at 15:33, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 4.99% stake in Beazley plc through relevant securities holding. Form 8.3 filing under Takeover Code Form 8.3 Relevant Securities The Vanguard Group Inc. Stake Disclosure Beazley Plc
BRIEF published on 08/12/2026 at 15:32, 30 days 7 hours ago The Vanguard Group Discloses Stake in SEGRO plc Takeover Code Vanguard Group Shareholding Disclosure Stock Acquisition SEGRO PLC
PRESS RELEASE published on 08/12/2026 at 15:32, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses 5.45% stake in Rotork plc with 44,528,929 shares. Position disclosed on 12-Aug-2026 The Vanguard Group, Inc. Stake Disclosure Rotork Plc 44,528,929 Shares 12-Aug-2026
BRIEF published on 08/12/2026 at 15:32, 30 days 7 hours ago The Vanguard Group Discloses Position in LondonMetric Property and Others Form 8.3 Position Disclosure Vanguard Group LondonMetric Schroder Real Estate
PRESS RELEASE published on 08/12/2026 at 15:31, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc The Vanguard Group, Inc. discloses 1.40% interest in Gamma Communications plc. Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 Rule 8.3 Takeover Code Vanguard Group Gamma Communications PLC
PRESS RELEASE published on 08/12/2026 at 15:31, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.71% ownership in Schroders plc as of 11 August 2026. Form 8.3 details the position disclosure Form 8.3 Position Disclosure The Vanguard Group Schroders Plc Ownership Disclosure
BRIEF published on 08/12/2026 at 15:30, 30 days 7 hours ago The Vanguard Group Discloses Position in Bodycote plc Disclosure Takeover Code Vanguard Group Shareholding Bodycote PLC
PRESS RELEASE published on 08/12/2026 at 15:30, 30 days 7 hours ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.76% ownership of Tate & Lyle plc securities on Form 8.3 under Rule 8.3 of the Takeover Code Securities Form 8.3 The Vanguard Group Ownership Disclosure Tate & Lyle Plc
Published on 09/11/2026 at 21:25, 1 hour 20 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 5 hours 45 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 7 hours 20 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 7 hours 45 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 22:15, 30 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 35 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 4 hours 30 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 15 hours 45 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 15 hours 45 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
